share_log

The Recent CN¥751m Market Cap Decrease Is Likely to Have Disappointed Insiders Invested in Chengdu Bright Eye Hospital Co., Ltd. (SZSE:301239)

The Recent CN¥751m Market Cap Decrease Is Likely to Have Disappointed Insiders Invested in Chengdu Bright Eye Hospital Co., Ltd. (SZSE:301239)

最近7.51億元人民幣的市值下降可能會讓投資成都光明眼科醫院有限公司(深圳證券交易所代碼:301239)的內部人士感到失望
Simply Wall St ·  04/13 21:10

Key Insights

關鍵見解

  • Insiders appear to have a vested interest in Chengdu Bright Eye Hospital's growth, as seen by their sizeable ownership
  • A total of 3 investors have a majority stake in the company with 50% ownership
  • Institutions own 26% of Chengdu Bright Eye Hospital
  • 業內人士似乎對成都光明眼科醫院的發展有既得利益,從他們龐大的所有權來看
  • 共有3名投資者持有該公司的多數股權,所有權爲50%
  • 機構擁有成都光明眼科醫院 26% 的股份

A look at the shareholders of Chengdu Bright Eye Hospital Co., Ltd. (SZSE:301239) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are individual insiders with 44% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

看看成都光明眼科醫院有限公司(SZSE: 301239)的股東可以告訴我們哪個集團最強大。而持有最大份額的集團是擁有44%所有權的個人內部人士。換句話說,該集團將從對公司的投資中獲得最多(或損失最大)。

And last week, insiders endured the biggest losses as the stock fell by 8.9%.

上週,由於該股下跌了8.9%,內部人士遭受了最大的損失。

Let's delve deeper into each type of owner of Chengdu Bright Eye Hospital, beginning with the chart below.

讓我們從下圖開始,深入研究成都光明眼科醫院的每種類型的所有者。

ownership-breakdown
SZSE:301239 Ownership Breakdown April 14th 2024
SZSE: 301239 所有權明細 2024 年 4 月 14 日

What Does The Institutional Ownership Tell Us About Chengdu Bright Eye Hospital?

關於成都光明眼科醫院,機構所有權告訴我們什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構在向自己的投資者報告時通常會根據基準來衡量自己,因此,一旦股票被納入主要指數,他們通常會對股票更加熱情。我們預計大多數公司都會有一些機構在冊,尤其是在它們正在成長的情況下。

We can see that Chengdu Bright Eye Hospital does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Chengdu Bright Eye Hospital's historic earnings and revenue below, but keep in mind there's always more to the story.

我們可以看到,成都光明眼科醫院確實有機構投資者;他們持有公司很大一部分股票。這表明專業投資者有一定的信譽。但是我們不能僅僅依靠這個事實,因爲機構有時會像所有人一樣進行不良投資。當多家機構擁有一隻股票時,總是存在處於 “擁擠交易” 的風險。當這樣的交易出錯時,多方可能會競相快速出售股票。對於沒有增長曆史的公司,這種風險更高。你可以在下面看到成都光明眼科醫院的歷史收益和收入,但請記住,故事總是有更多。

earnings-and-revenue-growth
SZSE:301239 Earnings and Revenue Growth April 14th 2024
SZSE: 301239 2024年4月14日收益和收入增長

Hedge funds don't have many shares in Chengdu Bright Eye Hospital. Xuyang Xu is currently the largest shareholder, with 43% of shares outstanding. In comparison, the second and third largest shareholders hold about 4.0% and 3.4% of the stock.

對沖基金在成都光明眼科醫院的股份不多。徐旭陽目前是最大股東,已發行股份的43%。相比之下,第二和第三大股東持有約4.0%和3.4%的股份。

To make our study more interesting, we found that the top 3 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

爲了使我們的研究更有趣,我們發現前三名股東擁有公司的多數股權,這意味着他們足夠強大,足以影響公司的決策。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There is some analyst coverage of the stock, but it could still become more well known, with time.

雖然研究公司的機構所有權可以爲您的研究增加價值,但研究分析師的建議以更深入地了解股票的預期表現也是一種好做法。有一些分析師對這隻股票的報道,但隨着時間的推移,它仍可能變得更加廣爲人知。

Insider Ownership Of Chengdu Bright Eye Hospital

成都光明眼科醫院的內部所有權

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

儘管內部人士的確切定義可能是主觀的,但幾乎每個人都認爲董事會成員是內部人士。管理層最終對董事會負責。但是,經理成爲執行委員會成員的情況並不少見,尤其是當他們是創始人或首席執行官時。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲這可能表明董事會與其他股東關係良好。但是,在某些情況下,過多的權力集中在該群體中。

It seems insiders own a significant proportion of Chengdu Bright Eye Hospital Co., Ltd.. It is very interesting to see that insiders have a meaningful CN¥3.4b stake in this CN¥7.7b business. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.

看來內部人士擁有成都光明眼科醫院有限公司的很大一部分股份。有趣的是,內部人士在這項77億元的業務中擁有34億元人民幣的大量股份。很高興看到這樣的投資水平。你可以在這裏查看這些內部人士最近是否在買入。

General Public Ownership

一般公有制

With a 21% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Chengdu Bright Eye Hospital. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

成都光明眼科醫院擁有 21% 的所有權,公衆對成都光明眼科醫院有一定程度的影響力,主要是個人投資者。儘管這種所有權規模可能不足以影響對他們有利的政策決定,但它們仍然可以對公司政策產生集體影響。

Private Company Ownership

私人公司所有權

Our data indicates that Private Companies hold 8.8%, of the company's shares. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

我們的數據顯示,私營公司持有公司8.8%的股份。私營公司可能是關聯方。有時,內部人士通過控股私營公司而對上市公司擁有權益,而不是以個人身份擁有權益。儘管很難得出任何寬泛的結論,但值得注意的是,這是一個需要進一步研究的領域。

Next Steps:

後續步驟:

While it is well worth considering the different groups that own a company, there are other factors that are even more important.

雖然值得考慮擁有公司的不同群體,但還有其他更爲重要的因素。

I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow, for free.

我喜歡更深入地了解一家公司過去的表現。您可以免費訪問這張過去的收益、收入和現金流的交互式圖表。

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果你像我一樣,你可能需要考慮這家公司是會成長還是會萎縮。幸運的是,您可以查看這份免費報告,其中顯示了分析師對其未來的預測。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論